Morepen Laboratories Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹570.13 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹570.13 crore. This corresponds to a year-on-year *(YoY) growth of 17.62 per cent.
Operating Profit
Operating Profit stands at ₹82.54 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹82.54 crore. This corresponds to a year-on-year *(YoY) growth of 237.59 per cent.
PBDT
PBDT stands at ₹82.88 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹82.88 crore. This corresponds to a year-on-year *(YoY) growth of 185.40 per cent.
Profit Before Tax
Profit Before Tax stands at ₹74.53 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹74.53 crore. This corresponds to a year-on-year *(YoY) growth of 220.01 per cent.
Net Profit
Net Profit stands at ₹56.35 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹56.35 crore. This represents a 258.92 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Morepen Laboratories Ltd News
Morepen Laboratories Ltd Earnings
- YOY
- QOQ
Morepen Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Morepen Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Morepen Laboratories Ltd Financial Reports
Morepen Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Morepen Labs. | 4.97% | -6.41% | 20.33% | 108.36% | 209.79% | 165.86% |
| Aarti Pharma | -1.74% | -1.29% | 9.98% | 20.81% | 23.56% | 3.77% |
| Supriya Lifesci. | -1.06% | 1.13% | -0.33% | 2.25% | 36.80% | 20.99% |
| Bliss GVS Pharma | -1.89% | -1.65% | -3.81% | 28.53% | 157.09% | 335.06% |
| Entero Healthcar | -0.44% | -5.01% | -10.98% | 30.04% | 30.02% | 47.26% |
| Sanofi India | 0.72% | 0.19% | -4.57% | -11.46% | -15.19% | -36.44% |
| SPARC | 1.75% | 2.18% | 2.02% | -23.52% | 27.32% | 46.51% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Sushil Suri
WTD & Executive Director : Sanjay Suri
Independent Non Exe. Director : Praveen Kumar Dutt
Independent Non Exe. Director : Ranjit Khattar
Independent Non Exe. Director : Savita
Independent Non Exe. Director : Sharad Jain
Company Secretary : Vipul Kumar Srivastava